Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Dinutuximab,Cyclophosphamide,Topotecan Hydrochloride
Therapeutic Area : Oncology
Study Phase : Phase II
Sponsor : AGC Biologics
Deal Size : Undisclosed
Deal Type : Agreement
Essential Pharma & AGC Biologics Partner for Immunotherapy Manufacturing for Neuroblastoma
Details : AGC Biologics will produce Hu1418K322A (Hu14.18), a humanised monoclonal antibody being developed for Essential Pharma for the treatment of high-risk neuroblastoma (HRNB).
Product Name : Hu14.18K322A
Product Type : Antibody
Upfront Cash : Undisclosed
November 06, 2024
Lead Product(s) : Dinutuximab,Cyclophosphamide,Topotecan Hydrochloride
Therapeutic Area : Oncology
Highest Development Status : Phase II
Sponsor : AGC Biologics
Deal Size : Undisclosed
Deal Type : Agreement
Lead Product(s) : Apomorphine Hydrochloride
Therapeutic Area : Ophthalmology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Iopidine (apraclonidine hydrochloride), is an alpha2-adrenergic agonist, a sympathomimetic used in glaucoma therapy. It is used as a short-term adjunctive therapy in open-angle glaucoma who are on maximally tolerated medical therapy requiring additional ...
Product Name : Iopidine
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 16, 2023
Lead Product(s) : Apomorphine Hydrochloride
Therapeutic Area : Ophthalmology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Apomorphine Hydrochloride
Therapeutic Area : Ophthalmology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : IOPIDINE (apraclonidine hydrochloride), is a short-term adjunctive therapy for chronic glaucoma to prevent or control intraocular pressure including after selective laser therapy, a form of laser eye surgery now recommended as the initial treatment for o...
Product Name : Iopidine
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 15, 2022
Lead Product(s) : Apomorphine Hydrochloride
Therapeutic Area : Ophthalmology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable